Protocol for the DREAMER study: Design and methodological framework of a multicenter trial-ready cohort of individuals with isolated REM sleep without atonia. [PDF]
Ferri R +7 more
europepmc +1 more source
CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone: An Explorative Pharmacogenetic Study. [PDF]
Wiss FM +7 more
europepmc +1 more source
Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response. [PDF]
Petković Ćurčin A +7 more
europepmc +1 more source
The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocol. [PDF]
Parent JH +3 more
europepmc +1 more source
Navigating Complexity in the Precision Oncology Clinic: Pharmacists' Central Role in Drug Selection, Acquisition, and Dosing in a Real-World Clinic. [PDF]
Grahl J +6 more
europepmc +1 more source
The role of tissue-based biomarkers in isolated REM sleep behavior disorder: implications for early detection and prognostication. [PDF]
Baumgartner AJ, Amara AW.
europepmc +1 more source
REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials. [PDF]
Neilson LE, Khattab YI, Lim MM.
europepmc +1 more source
Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use. [PDF]
Baune BT.
europepmc +1 more source
Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohort. [PDF]
Maestri M +38 more
europepmc +1 more source

